jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Anti-Streptolysin O (ASO)

Bacterial/ Viral
image

Report in 4Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

ASO antibodies are produced by the immune system in response to an infection caused by Group A Streptococcus (Streptococcus pyogenes). The bacteria secrete a toxin called streptolysin O, which is harmful to red blood cells. The ASO test detects antibodies against this toxin

299473

37% OFF

Anti-Streptolysin O (ASO) Test - Comprehensive Medical Guide

  • Why is it done?
    • Test Purpose: The ASO test measures antibodies produced by the immune system in response to Group A Streptococcal (Group A Strep) infection. It detects previous or current streptococcal exposure by identifying antistreptolysin O antibodies in the blood.
    • Primary Indications: Diagnosis of acute rheumatic fever (ARF) or post-streptococcal glomerulonephritis (PSGN); evaluation of patients with suspected rheumatic heart disease; confirmation of recent Group A Streptococcal infection when clinical diagnosis is uncertain
    • Clinical Circumstances: Ordered 2-3 weeks after Group A Streptococcal pharyngitis (throat infection); when patients present with joint pain, fever, and cardiac symptoms; during evaluation of new-onset heart murmur; in cases of recurrent streptococcal infections
  • Normal Range
    • Reference Values: Less than 200 IU/mL (International Units per milliliter) or less than 1:200 titer (when reported as titer); specific cutoff values may vary by laboratory and testing method
    • Normal Result: Negative result indicates no recent Group A Streptococcal infection or remote/past infection with waning antibodies
    • Elevated Result: Greater than 200 IU/mL or 1:200 titer suggests recent or acute Group A Streptococcal infection
    • Borderline Values: Values between 200-300 IU/mL may be considered borderline; serial testing (repeat ASO titer in 2 weeks) is recommended to detect rising antibody titers, which is more significant than a single elevated value
    • Units of Measurement: IU/mL (International Units per milliliter) or reported as titer ratios (1:200, 1:400, etc.)
  • Interpretation
    • Negative Result (<200 IU/mL): Suggests no recent Group A Streptococcal infection; makes acute rheumatic fever or acute glomerulonephritis less likely (though does not completely exclude recent infection in early phase); may indicate past infection with declining antibody levels
    • Single Elevated Result (>200 IU/mL): Indicates past or recent streptococcal infection; cannot definitively distinguish between recent and remote infection; a single elevated titer is less specific than rising titers
    • Rising Titer (Fourfold Increase): Comparing two samples 2-3 weeks apart showing a fourfold rise is highly significant and indicates recent or acute Group A Streptococcal infection; strongly suggestive of acute rheumatic fever or post-streptococcal sequelae
    • Falling Titer: Suggests infection occurred in the distant past with declining immune response; indicates resolution of acute phase
    • Factors Affecting Results: Timing of test (elevated levels peak 3-6 weeks after infection); previous streptococcal infections; prophylactic penicillin use (may suppress antibody response); immunosuppressive conditions; chronic streptococcal infection; rheumatoid factor or other autoimmune conditions; laboratory methodology variations
    • Clinical Significance: Most useful when combined with clinical presentation and other diagnostic tests (throat culture, rapid strep test); serial testing more valuable than single result; approximately 80% of patients with acute rheumatic fever have elevated ASO titers; 90% of patients with post-streptococcal glomerulonephritis show elevated levels
  • Associated Organs
    • Primary Organ Systems: Cardiovascular system (heart and valves); nervous system; musculoskeletal system (joints); kidneys; respiratory tract (throat/pharynx)
    • Associated Diseases - Acute Rheumatic Fever (ARF): Inflammatory disease following Group A Streptococcal pharyngitis; affects heart (myocarditis, endocarditis, pericarditis); causes joint inflammation (polyarthritis); may involve nervous system (Sydenham's chorea); skin manifestations (erythema marginatum, subcutaneous nodules)
    • Associated Diseases - Post-Streptococcal Glomerulonephritis (PSGN): Immune-mediated kidney inflammation; follows Group A Streptococcal pharyngitis; presents with hematuria, proteinuria, and hypertension; can lead to renal failure if severe
    • Associated Diseases - Rheumatic Heart Disease (RHD): Chronic sequela of acute rheumatic fever; causes permanent heart valve damage; leads to valvular stenosis or regurgitation; can result in heart failure and atrial fibrillation
    • Potential Complications: Permanent cardiac damage and valve dysfunction; stroke (from cardioemboli or atrial fibrillation); heart failure; renal failure; recurrent streptococcal infections if not properly managed; endocarditis risk (especially with prosthetic valves)
  • Follow-up Tests
    • Repeat ASO Titer: Recommended 2-3 weeks after initial test to assess for rising titer (fourfold or greater increase indicates recent infection); more diagnostically significant than single elevated value
    • Anti-DNase B Titer: Complementary test for streptococcal antibodies; useful when ASO is negative but clinical suspicion remains high; can detect streptococcal infection in cases where ASO testing is inconclusive
    • Erythrocyte Sedimentation Rate (ESR): Measures inflammation; elevated in acute rheumatic fever; used to assess disease activity and monitor treatment response
    • C-Reactive Protein (CRP): Acute phase reactant; elevated in acute rheumatic fever and active infection; helps monitor inflammatory status and response to anti-inflammatory therapy
    • Echocardiography: Ultrasound of the heart; essential for detecting cardiac involvement in acute rheumatic fever; evaluates valve function, chamber size, and ventricular function; used for baseline assessment and monitoring
    • Electrocardiogram (ECG): Records heart electrical activity; may show conduction abnormalities, arrhythmias, or signs of inflammation in acute rheumatic fever
    • Renal Function Tests: Blood urea nitrogen (BUN), creatinine; assess kidney function if post-streptococcal glomerulonephritis is suspected; monitor for complications
    • Urinalysis: Detects hematuria and proteinuria; useful when glomerulonephritis is suspected following streptococcal infection
    • Throat Culture or Rapid Strep Test: Confirms Group A Streptococcal throat infection; most useful when performed early in illness before antibodies develop; provides direct microbiological evidence
    • Monitoring Frequency: For acute rheumatic fever: baseline and follow-up testing to confirm diagnosis; for established rheumatic heart disease: periodic echocardiography (annually or as clinically indicated); for secondary prophylaxis monitoring: as directed by cardiologist; ASO levels typically do not require routine monitoring once diagnosis is established
  • Fasting Required?
    • Fasting Requirement: No - Fasting is NOT required for the ASO test. Blood can be drawn at any time of day regardless of food or fluid intake.
    • Fluid Intake: No restrictions; normal water intake is acceptable and may be beneficial for adequate hydration before blood draw
    • Medications: Continue all regular medications as prescribed; no medications need to be withheld before ASO testing; inform healthcare provider of any immunosuppressive medications as these may affect antibody levels
    • Patient Preparation: Wear comfortable, loose-fitting clothing with easily accessible sleeves for venipuncture; inform phlebotomist of any needle anxiety or previous difficult blood draws; remain calm and relax arm muscles during blood collection; no special preparation is needed
    • Timing Considerations: Test should be performed 2-3 weeks after suspected streptococcal infection for optimal antibody detection; initial specimen can be collected at any time; for serial testing, second sample ideally collected 2-3 weeks after the first specimen
    • Special Instructions: No special instructions necessary; standard blood draw procedures apply; serum or plasma may be collected depending on laboratory preference; samples are typically stable and can be transported according to standard laboratory protocols

How our test process works!

customers
customers